Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
United States: 1-888-708-7444 or 1-919-852-4685
France: +33 1 56 95 17 10
Germany: +49 89 45 10 300
United Kingdom: +44 (0) 114 292 2322
India: +91 984 500 6625
Interested in Certara's biosimulation solutions? Want to speak to someone in our sales team? Click on the link below!
Certara Strategic Consulting provides high-quality, regulatory-complaint PK/PD analyses that are the basis of your regulatory submission package. On more than 100 client engagements per year, our pharmacometricians apply our world-class expertise and technology to support nonclinical and clinical study analysis for new drug approvals.
We use the latest versions of Phoenix® WinNonlin®, Phoenix NLME™, IVIVC Toolkit™ for Phoenix WinNonlin, and the Phoenix Knowledgebase Server™ Online (PKS™ Online) to ensure that your analyses are carried out to the highest professional standards, in minimum time, at competitive rates.
Our methods are simple, efficient, and robust. You receive the highest quality analysis, leading to protocols optimized for:
We can support your strategic drug development decisions and new drug approvals through quantitative analysis and predictive models of diseases, drugs and clinical trials.